Securities Report – 72nd Fiscal Period (April 1, 2025 – March 31, 2026)
AI Summary (NQ-processed)
Zeria Pharmaceutical Co., Ltd. has filed its Securities Report for the 72nd fiscal period (April 1, 2025 – March 31, 2026). This document provides comprehensive financial and management information as required by regulatory standards.
AI Analysis
Frequently Asked Questions
Q: What is the 72nd fiscal period for Zeria Pharmaceutical?
A: The 72nd fiscal period runs from April 1, 2025 to March 31, 2026.
Q: What is a Securities Report?
A: A mandatory annual filing by listed companies disclosing financial and management information for investors.
Q: What does Zeria Pharmaceutical do?
A: It develops, manufactures, and markets pharmaceuticals focused on gastrointestinal and CNS disorders.
Q: Why is this report important for investors?
A: It provides key insights into financial performance, strategy, and risk factors for informed decision-making.
Q: Where is Zeria Pharmaceutical headquartered?
A: The headquarters is located in Nihonbashi-Honcho, Chuo-ku, Tokyo.